Salivary Flow Promoted by Sugar-Free Chewing Gum

NCT ID: NCT05447104

Last Updated: 2022-07-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

16 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-09-22

Study Completion Date

2021-11-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This was a double-blind, single center in vivo salivary flow rate study. The objective was to compare a marketed sugar-free chewing gum to a clinically-tested sugar-free reference chewing gum, with regards to their ability to promote salivary flow during a 20-minute chew period in healthy human adult subjects. Two sugar-free chewing gums were randomly assigned and distributed in a cross-over fashion to study subjects over two test period visits. The primary response being measured was salivary flow promoted by sugar-free chewing gums during the 20-minute chewing period.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

These procedures were conducted in accordance with proposed guidelines for current good clinical practices. Informed consent was obtained in compliance with FDA regulations (21 CFR 50). Each subject read, understood, signed, and received a signed copy of the most current IRB approved informed consent document prior to any study-related procedures being performed. The test and control gums were provided by the Sponsor. One serving size of each gum type was placed in a labeled, small high barrier foil bag to ensure that the subjects and the site personnel received the gum in a blinded manner. During each of the test visits, subjects: 1) provided a non-stimulated saliva sample to ensure continued qualification, 2) received their assigned chewing gum, and 3) provided stimulated saliva over a timed 20-minute chewing period. The primary response being measured was the salivary flow promoted by each chewing gum.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Saliva Altered

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

prospectively planned, double-blind, single center cross-over study
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors
Double blind

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ADA Clinically-Tested Reference Sugar-Free Gum

Peppermint flavored sugar-free chewing gum (1 piece = 2.2 grams)

Group Type ACTIVE_COMPARATOR

Mastication

Intervention Type BEHAVIORAL

Chewing sugar-free gum for 20 min

Marketed Gum: Sugar-free gum

Orbit White, peppermint flavored sugar-free chewing gum Mars Wrigley Confectionary US, LLC (1 piece = 2.0 grams)

Group Type EXPERIMENTAL

Mastication

Intervention Type BEHAVIORAL

Chewing sugar-free gum for 20 min

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mastication

Chewing sugar-free gum for 20 min

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* be at least 18 years of age
* have the ability to understand the information contained in the informed consent without the need for cognitive or language interpretation from any other person or source
* read, comprehend and sign the Informed Consent and other necessary paperwork prior to initiation of study procedures
* be in good general health based on his/her medical and dental history
* have a reasonably functional dentition with a minimum of 20 natural teeth (8 of which are posterior teeth)
* chew gum at least occasionally, no less than one time per month
* have normal salivary flow as demonstrated by being able to expectorate ≥ 1.5 mL (0.3 mL/min) of whole non-stimulated saliva over a 5-minute period
* be willing to participate in the study, be able to follow the study directions, and be willing to return for all specified visits at their appointed time, and
* be willing to postpone all elective dental procedures, at the Principal Investigator/Examiner's discretion, until the study has been completed.

Exclusion Criteria

* advanced periodontal disease
* five or more grossly decayed, untreated dental sites (cavities)
* pathologic lesions of the oral cavity (suspicious or confirmed)
* full or partial dentures, or fixed orthodontic appliances, with the exception of a fixed, lower lingual retainer
* (if female) a medical history indicating that the subject is pregnant or currently breastfeeding
* current participation in another clinical research study or recent participation in another clinical trial (within 30 days of the study start date) may be cause for exclusion, based on the discretion of the Principal Investigator/Dental Examiner
* a history of a true allergy or intolerance to gum ingredients, including (but not limited to) sweeteners, colors or flavors, mint, peppermint, spearmint, milk proteins, or other ingredients which may be present in the study products
* Have a serious medical illness or disorder, e.g., immune compromised, AIDs, etc., that would be unduly affected by participation in this study, per the Principal Investigator/Dental Examiner's discretion
* a history of PKU (an intolerance to phenylalanine)
* a true food allergy to soy, or
* a history of temporomandibular disorder (TMD).
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mars Wrigley

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bruce A Matis

Role: PRINCIPAL_INVESTIGATOR

Therametric Technologies, Inc.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Therametric Technologies, Inc.

Noblesville, Indiana, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

M.WRI-2021-SAL-03

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Stannous Fluoride and Gingivitis
NCT05326373 COMPLETED NA
Pilot Efficacy Study to Treat Gingivitis
NCT00391547 COMPLETED PHASE2